Tìm kiếm
Adlai Nortye Ltd
ANLThêm vào danh sách theo dõi
15.570USD
-0.170-1.08%
Đóng cửa 09-18 16:00（ET）
743.45MVốn hóa
LỗP/E TTM
Thêm thông tin về Adlai Nortye Ltd Công ty
Adlai Nortye Ltd. is a Cayman Islands-based investment holding company. The Company is involved in the research and development of pharmaceutical products. It is a clinical-stage company focused on the development of targeted and immune-modulating cancer therapies. It is advancing an oncology pipeline, with Buparlisib (AN2025), a pan-phosphoinositide 3-kinase (PI3K) inhibitor, being evaluated in a registrational Phase three trial (NCT04338399) for patients with recurrent or metastatic head and neck squamous cell cancer (HNSCC) that has progressed after prior anti-programmed death-ligand 1 (PD-L1) treatment. It is also advancing multiple drug candidates, including AN4005, an oral small molecule PD-L1 inhibitor; AN8025, a multifunctional fusion protein acting as a T cell and antigen-presenting cell (APC) modulator; and AN9025, an oral small molecule pan-rat sarcoma virus (RAS) inhibitor. The Company’s subsidiary, Alpine Bioscience Ltd. (Alpine BVI), is an investment holding company.
Adlai Nortye Ltd Hồ sơ
Mã chứng khoánANL
Tên công tyAdlai Nortye Ltd
Ngày IPOSep 29, 2023
Giám đốc điều hànhBirgerson (Lars Erik)
Số lượng nhân viên123
Loại chứng khoánDepository Receipt
Kết thúc năm tài chínhSep 29
Địa chỉc/o PO Box 309
Thành phốGRAND CAYMAN
Sàn giao dịch chứng khoánNASDAQ OMX - NASDAQ BASIC
Quốc giaCayman Islands
Mã bưu điệnKY1-1104
Điện thoại18482307430
Trang webhttps://www.adlainortye.com/
Mã chứng khoánANL
Ngày IPOSep 29, 2023
Giám đốc điều hànhBirgerson (Lars Erik)
Lãnh đạo công ty của Adlai Nortye Ltd
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Lars Erik Birgerson
Mr. Lars Erik Birgerson
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
166.67K
--
Mr. Lars Erik Birgerson
Mr. Lars Erik Birgerson
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
166.67K
--
Mr. Lars Erik Birgerson
Mr. Lars Erik Birgerson
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
166.67K
--
Mr. Lars Erik Birgerson
Mr. Lars Erik Birgerson
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
166.67K
--
Ms. Ping Ji
Ms. Ping Ji
Director Nominee
Director Nominee
136.67K
--
Ms. Ping Ji
Ms. Ping Ji
Director Nominee
Director Nominee
136.67K
--
Ms. Ping Ji
Ms. Ping Ji
Director Nominee
Director Nominee
136.67K
--
Ms. Ping Ji
Ms. Ping Ji
Director Nominee
Director Nominee
136.67K
--
Mr. Yang Lu
Mr. Yang Lu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
99.99K
-0.01%
Mr. Yang Lu
Mr. Yang Lu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
99.99K
-0.01%
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Lars Erik Birgerson
Mr. Lars Erik Birgerson
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
166.67K
--
Mr. Lars Erik Birgerson
Mr. Lars Erik Birgerson
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
166.67K
--
Mr. Lars Erik Birgerson
Mr. Lars Erik Birgerson
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
166.67K
--
Mr. Lars Erik Birgerson
Mr. Lars Erik Birgerson
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
President, Director Nominee, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary
166.67K
--
Ms. Ping Ji
Ms. Ping Ji
Director Nominee
Director Nominee
136.67K
--
Ms. Ping Ji
Ms. Ping Ji
Director Nominee
Director Nominee
136.67K
--
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Adlai Nortye Ltd?
Năm cổ đông hàng đầu của Adlai Nortye Ltd là: Mr. Lars Erik Birgerson
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Adlai Nortye Ltd (ANL)?
Tính đến ngày 2026Q1, có 13 tổ chức nắm giữ cổ phiếu của Adlai Nortye Ltd, với tổng giá trị thị trường khoảng 3.40M, chiếm 7.18% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm 3307188.00.